WNT5A and breast carcinoma: Comparison of recurrence-free survival, for which 5-year survival rates were 81.1% and 100% in Wnt5a-positive and Wnt5a-negative breast cancers, respectively, revealed a significant difference according to statistical analysis using the log-rank test (P = 0.024) (Figure 2).